CHE Stock Recent News
CHE LATEST HEADLINES
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Chemed (CHE) possesses solid growth attributes, which could help it handily outperform the market.
Chemed's (CHE) VITAS segment delivers impressive revenue growth and margin expansion in the second quarter of 2024.
Chemed (CHE) came out with quarterly earnings of $5.47 per share, missing the Zacks Consensus Estimate of $5.54 per share. This compares to earnings of $4.71 per share a year ago.
Chemed's (CHE) robust VITAS business and strong financial stability raise investors' optimism.
Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, July 25, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through th.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at approximately 9:00 a.m. (ET) at the New York Marriott Marquis in New York City. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the.
CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2024 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2024. Stockholders also approved Chemed's executive compensation. In addition, stockholders voted against the stockholder proposal on ratification of termination pay. Dividend Declared Following the stockholders' meeting.
Chemtrade Logistics Income Fund (OTC:CGIFF) Q1 2024 Earnings Conference Call May 16, 2024 8:30 AM ET Company Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President and CEO Conference Call Participants Jacob Bout - CIBC Anthony Taglieri - BMO Capital Markets Gary Ho - Desjardins Capital Markets Steve Hansen - Raymond James Zachary Evershed - National Bank Financial Operator Good morning, ladies and gentlemen, and welcome to the Chemtrade Logistics Income Fund Q1 2024 Conference Call. At this time, all lines are in a listen-only mode.